CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Cash flows from operating activities:
Net Income (Loss)	$ 2,094	$ 28,829
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	16,791	15,252
Amortization of debt discount and issuance costs	3,809	457
Stock-based compensation	8,776	7,254
Deferred income taxes, net	(833)	(1,124)
Contingent consideration	0	1,235
Other	(105)	(857)
Changes in operating assets and liabilities, excluding impact of acquisitions:
Accounts receivable	6,653	(16,832)
Inventories	3,167	(5,845)
Prepaid expenses and other assets	(4,571)	(2,799)
Operating lease right of use assets	(19,465)	3,349
Other assets	320	(434)
Accounts payable	(645)	(1,194)
Accrued expenses	6,381	(13,326)
Operating lease Liabilities	22,484	(2,870)
Long-term liabilities	(148)	59
Total cash provided by operating activities	44,708	11,154
Cash flows from investing activities:
Additions to capitalized software costs	(27)	(924)
Purchases of property, plant and equipment	(8,346)	(8,509)
Other investing activities	11	0
Total cash used in investing activities	(8,362)	(9,433)
Cash flows from financing activities:
Proceeds from exercise of stock options	945	29
Payment of tax withholding obligation on vesting of restricted stock	(7,622)	(9,592)
Payment of earnout consideration	(2,160)	0
Other financing activities	(137)	0
Total cash used in financing activities	(8,974)	(9,563)
Effect of exchange rate changes on cash and cash equivalents	1,922	993
Net increase (decrease) in cash and cash equivalents	29,294	(6,849)
Cash, cash equivalents and restricted cash, beginning of period	751,323	523,458
Cash and cash equivalents, end of period	780,617	516,609
Supplemental disclosure of non-cash investing and financing activities:
Assets acquired under operating leases	23,093	179
Fair value of shares of common stock issued for contingent consideration earnouts	$ 541	$ 0